Lincoln, Neb., and Pleasanton, Calif. – November 30, 2021 – Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, today announced it has raised $46 million in a Series C funding round.

In addition to cultivate(MD) being a key investor in this Series C, Genesis Innovation Group also helped play a significant role in assisting with the facilitation of this round of funding for Virtual Incision.

The funds will be used to support regulatory and clinical programs leading to the commercialization of the company’s MIRA® (“miniaturized in vivo robotic assistant”) Surgical Platform.

“Virtual Incision’s goal is to transform surgery by providing a practical and hassle-free platform that will enable efficient, effective, and affordable access to robotic-assisted technology regardless of the site of care. We are excited that this funding will support our efforts to advance MIRA, so that more patients can ultimately experience the benefits of minimally invasive surgery.”

John Murphy, CEO